Yoon Jeon - Concepedia

Author

Yoon Jeon

Bristol-Myers Squibb (United States)

Also Known As

Y. T. JEON, Yeong-Ju Jeon, Yoon Jeon, Yoon T. Jeon

Publications

465

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)

About

Yoon Jeon is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	155
2	Biochemistry	4	4	64
3	Natural Sciences	3	3	48
4	Health Sciences	1	1	80
5	Cell Biology	1	1	80

Yoon Jeon

Publications

449

Citations

H-Index

Page 1

	Year	Citations
The First Total Synthesis of (±)-Ingenol Jeffrey D. Winkler, Meagan B. Rouse, Michael F. Greaney, Journal of the American Chemical Society	2002	165
Design and Synthesis of <i>N</i>-[(4-Methoxyphenoxy)carbonyl]-<i>N</i>-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist with Efficacious Glucose and Lipid-Lowering Activities Pratik Devasthale, Sean Chen, Yoon Jeon, Journal of Medicinal Chemistry	2004	108
Muraglitazar, a Novel Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, Improves Diabetes and Other Metabolic Abnormalities and Preserves β-Cell Function in <i>db/db</i> Mice Thomas Harrity, Dennis Farrelly, Aaron Tieman, Diabetes Ppar Target GenesImmunologyPharmacotherapyMetabolic RemodelingInsulin Signaling	2006	80
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species Wu Yang, Yufeng Wang, Amy Lai, Journal of Medicinal Chemistry	2020	21
Identification of 1-{2-[4-chloro-1′-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4′-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y1 antagonist as an antiplatelet agent Yoon Jeon, Wu Yang, Jennifer X. Qiao, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryAntimicrobial Drug DiscoveryPharmaceutical ChemistryPharmaceutical Science	2014	19
De Novo Design of a Novel Oxazolidinone Analogue as a Potent and Selective α<sub>1A</sub> Adrenergic Receptor Antagonist with High Oral Bioavailability Bharat Lagu, Dake Tian, Yoon Jeon, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyExperimental PharmacologyNovel Oxazolidinone Analogue	2000	17
Discovery of tertiary aminoacids as dual PPARα/γ agonists-I Pratik Devasthale, Sean Chen, Yoon Jeon, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineTertiary AminoacidsReceptor (Biochemistry)	2007	16
Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability Charles G. Clark, Karen A. Rossi, James R. Corte, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryImproved Oral BioavailabilityPharmaceutical ScienceBiochemistryMedicine	2019	12
Pharmacological evaluation of UK-14,304 analogs at cloned human α adrenergic receptors Yoon Jeon, Chi Luo, Carlos Forray, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinePhysiologyReceptor (Biochemistry)Uk-14,304 Analogs	1995	11

Page 1